(Received for publication May 9, 1989) While screening for new antitumor agents from cultured broths, the culture Streptomyces albaduncus strain C38291 (ATCC 14698) was selected for further evaluation. This investigation led to the discovery of the known antitumor antibiotics chrysomycins V (1) and M (2)1}.
These compounds are members of a family of compounds possessing the benzonaphthopyranone ring system (Fig. 1) . Since there is considerable interest in this family of antitumor antibiotics not only as synthetic targets2~4) but also as to their mechanism of action5~15), we felt obligated to report our observations on the antitumor activity of chrysomycins V and M against various murine tumors.
Commentaryon Nomenclature Avariety of names have been used to identify a P388 and L1210 implants were 106 leukemic cell/mouse. For B16, each mouse received 0.5ml ofa 10% w/v tumor brei. Control median survival times were as follows: P388-9.0 days; L1210-7.0 days; B16-21.0days. Therewere6 CDFH1 miceineachtreatment group in the P388andL1210ex-periments, and 9~10 BDF1mice in each B16 experimental treatment group. Control groups in all experiments consisted of 10 mice. b The median survival time (MST) of treated mice/MST of control mice, xl00= % T/C. Significant activity was considered to be a T/C of >125%in each tumor model evaluated. c Twoof six mice had died by day-5 indicating excessive toxicity associated with this dosage. more potent and toxic against P388 leukemia than the parent compound. It is also differs from that which is reported for gilvocarcins V and M. Gilvocarcin M was inactive18). There has been considerable speculation about the mechanism of action for these benzonaphthopyranone compounds5~15). The vast majority of the studies have focused on the 8-vinyl group and light activation in in vitro models. However, the activity observed for chrysomycin Mand analogs of ravidomycin strongly suggest that other factors or modes of action must be involved in in vivo systems. Alternative hypotheses such as solubility18), transport170, inhibition of topoisomerase19), induction of topoisomerase II-dependent DNA cleavage19) and stronger or more stable binding to DNA6,io,n,i7,i9) ieading to cell death have been proposed. Clearly, the in vivo mechanism of action will require more careful evaluation to account for these observation. 
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